HOME >> BIOLOGY >> NEWS
New tool predicts how long pollutants will stay in soil

Building on an idea developed by medicinal chemists, Johns Hopkins researchers have devised a new mathematical tool that accurately predicts how long certain pollutants -- including pesticides and pharmaceuticals -- will remain in soil.

The work is timely because researchers and public officials have become increasingly concerned about pharmaceuticals and personal care products that have been detected in soil and water. Environmental engineers are seeking better ways to track these emerging pollutants, which tend to be more complex and water-soluble than previous contaminants of concern, such as chlorinated solvents and petroleum byproducts.

This new modeling approach is important because environmental regulators and cleanup consultants need to know the extent to which hazardous contaminants will linger on a piece of land and the rate at which they will migrate toward critical water resources and supplies. The new approach will help them decide whether the pollutants need to be removed and how best to accomplish this, the researchers say.

"If we release chemicals into the environment, we need to know what will happen to them," said Thanh Helen Nguyen, a graduate student who played a leading role in adapting the math tool and demonstrating its effectiveness. "For many years, we've made predictions with a method that doesn't work very well on many chemical pollutants in soil. This new tool does a much better job."

Nguyen, who is working toward her doctorate in the Department of Geography and Environmental Engineering, described the improved pollution predictor during an Aug. 26 presentation in Philadelphia at the 228th national meeting of the American Chemical Society.

Although her own training is in geology and environmental engineering, Nguyen said the new tool is based on a breakthrough by chemists who study how medications move from the bloodstream into human tissue. At an American Chemical Society meeting last year, Nguye
'"/>

Contact: Phil Sneiderman
prs@jhu.edu
443-287-9960
Johns Hopkins University
26-Aug-2004


Page: 1 2 3

Related biology news :

1. Hardy buoys: Texas A&M project predicts oil spill movements
2. Molecular marker predicts success of breast cancer treatment
3. Is that plant a tortoise or a hare? Answer predicts its response to environmental change
4. Brain signal predicts working memory prowess
5. New software developed at Rensselaer predicts promising ingredients for new drugs
6. Immunity gene predicts severe adverse drug reaction
7. New map predicts where wolves will attack
8. Study predicts conditions for sustainable lion trophy hunting
9. Inflammation marker predicts colon cancer
10. Doppler ultrasound predicts risk of miscarriage
11. Gliomas molecular fingerprint predicts how aggressive tumor will be

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New tool predicts how long pollutants will stay soil

(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Veolia’s ... an exclusive North American distribution agreement with VWR ... system. , With more than 160 years of ... and services for laboratory and production facilities, has ... excellence and differentiated services to enable science. ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
Cached News: